FSLBX
Price
$199.08
Change
+$2.26 (+1.15%)
Updated
Jan 14 closing price
Net Assets
1.21B
RYFNX
Price
$95.90
Change
+$0.36 (+0.38%)
Updated
Jan 14 closing price
Net Assets
11.09M
Interact to see
Advertisement

FSLBX vs RYFNX

Header iconFSLBX vs RYFNX Comparison
Open Charts FSLBX vs RYFNXBanner chart's image
Fidelity Select Brokerage & Inv Mgmt
Price$199.08
Change+$2.26 (+1.15%)
VolumeN/A
Net Assets1.21B
Rydex Financial Services A
Price$95.90
Change+$0.36 (+0.38%)
VolumeN/A
Net Assets11.09M
FSLBX vs RYFNX Comparison Chart in %
View a ticker or compare two or three
VS
FSLBX vs. RYFNX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSLBX is a Hold and RYFNX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSLBX has more cash in the bank: 1.21B vs. RYFNX (11.1M). RYFNX pays higher dividends than FSLBX: RYFNX (1.34) vs FSLBX (0.67). FSLBX was incepted earlier than RYFNX: FSLBX (40 years) vs RYFNX (21 years). RYFNX (1.69) is less costly to investors than FSLBX (0.69). RYFNX is a more actively managed with annual turnover of: 280.00 vs. FSLBX (16.00). FSLBX has a lower initial minimum investment than RYFNX: FSLBX (0) vs RYFNX (2500). RYFNX annual gain was more profitable for investors over the last year : 12.47 vs. FSLBX (10.51). FSLBX return over 5 years is better than : 109.68 vs. RYFNX (34.63).
FSLBXRYFNXFSLBX / RYFNX
Total Expense Ratio0.691.6442%
Annual Report Gross Expense Ratio0.691.6941%
Fund Existence40 years21 years-
Gain YTD3.1011.001310%
Front LoadN/A5%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.21B11.1M10,901%
Annual Yield % from dividends0.671.3450%
Returns for 1 year10.5112.4784%
Returns for 3 years75.0047.65157%
Returns for 5 years109.6834.63317%
Returns for 10 years280.28119.04235%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LGND196.547.76
+4.11%
Ligand Pharmaceuticals
PLX2.060.04
+1.98%
Protalix BioTherapeutics
CPF31.610.59
+1.90%
Central Pacific Financial Corp
GENK2.480.03
+1.22%
GEN Restaurant Group
IBKR71.350.76
+1.08%
Interactive Brokers Group Inc